Ethocle Reports has published its latest Market Research Report on Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.

1. DeepBrain Stimulators - Medical DevicesPipeline Assessment,2016
Ethocle Reportshaspublished its latest MarketResearch Reporton DeepBrain Stimulators - Medical
DevicesPipeline Assessment,2016. Formulatesignificantcompetitorinformation, analysis,and insights
to improveR&D strategies.Browsemarketdata tablesand figures.
PublishedOn: 01-Dec-2016 | Pages: 140
Summary
GlobalData'sMedical Devicessectorreport,“DeepBrainStimulators - Medical DevicesPipeline
Assessment,2016" providesanoverview of DeepBrainStimulatorscurrentlyinpipelinestage.
The report providescomprehensiveinformationonthe pipeline productswithcomparative analysisof
the productsat variousstagesof development.The reportreviewsmajorplayersinvolvedinthe pipeline
productdevelopment.Italsoprovidesinformationaboutclinical trialsinprogress,whichincludestrial
phase,trial status,trial start and enddates,and,the numberof trialsfor the keyDeepBrainStimulators
pipelineproducts.
Thisreportis preparedusingdatasourcedfromin-house databases,secondaryandprimaryresearchby
GlobalData'steamof industryexperts.
Click here to find out more about this report?
Scope
- Extensive coverage of the DeepBrainStimulatorsunder development
- The report reviewsdetailsof majorpipeline productswhichincludes,productdescription,licensing
and collaborationdetailsandotherdevelopmental activities
- The report reviewsthe majorplayersinvolvedinthe developmentof DeepBrainStimulatorsandlistall
theirpipeline projects
- The coverage of pipeline productsbasedonvariousstagesof developmentrangingfromEarly
DevelopmenttoApproved/Issuedstage
- The report provideskeyclinical trial dataof ongoingtrialsspecific topipeline products

2. - Recentdevelopmentsinthe segment/industry
Get Free Sample Report
Click here for Discounts
Reasons to buy
The report enablesyouto -
- Formulate significantcompetitorinformation,analysis,andinsightstoimprove R&Dstrategies
- Identifyemergingplayerswithpotentiallystrongproductportfolioandcreate effective counter-
strategiestogaincompetitiveadvantage
- Identifyandunderstandimportantanddiversetypesof DeepBrainStimulatorsunderdevelopment
- Developmarket-entryandmarketexpansionstrategies
- Planmergersandacquisitionseffectivelybyidentifyingmajorplayerswiththe mostpromisingpipeline
- In-depthanalysisof the product’scurrentstage of development,territoryandestimatedlaunchdate
Table of Contents
1.1 Listof Tables5
1.2 Listof Figures10
2 Introduction11
2.1 DeepBrainStimulatorsOverview 11
3 ProductsunderDevelopment12
3.1 DeepBrainStimulators - Pipeline ProductsbyStage of Development12
3.2 DeepBrainStimulators - Pipeline ProductsbyTerritory13
3.3 DeepBrainStimulators - Pipeline ProductsbyRegulatoryPath14
3.4 DeepBrainStimulators - Pipeline ProductsbyEstimatedApproval Date 15
3.5 DeepBrainStimulators - OngoingClinicalTrials16

3. 4 DeepBrainStimulators - PipelineProductsunderDevelopmentbyCompanies17
4.1 DeepBrainStimulatorsCompanies - Pipeline ProductsbyStage of Development17
4.2 DeepBrainStimulators - Pipeline ProductsbyStage of Development19
5 DeepBrainStimulatorsCompaniesandProductOverview 21
5.1 Adaptive NeuromodulationGmbHCompanyOverview 21
5.1.1 Adaptive NeuromodulationGmbHPipelineProducts&OngoingClinical TrialsOverview 21
5.2 AlevaNeurotherapeuticsSA CompanyOverview 22
5.2.1 AlevaNeurotherapeuticsSA PipelineProducts&OngoingClinical TrialsOverview 22
5.3 BostonScientificCorpCompanyOverview 25
5.3.1 BostonScientificCorpPipeline Products&OngoingClinical TrialsOverview 25
5.4 BrainswayLtdCompany Overview30
5.4.1 BrainswayLtd Pipeline Products&OngoingClinical TrialsOverview 30
5.5 Cerene Biomedics,Inc.CompanyOverview 40
5.5.1 Cerene Biomedics,Inc.Pipeline Products&OngoingClinical TrialsOverview 40
5.6 CerevastTherapeuticsIncCompanyOverview 41
5.6.1 CerevastTherapeuticsIncPipeline Products&OngoingClinical TrialsOverview 41
5.7 Children'sHospital BostonCompanyOverview42
5.7.1 Children'sHospital BostonPipeline Products&OngoingClinical TrialsOverview 42
5.8 ClevelandMedical DevicesIncCompanyOverview 43
5.8.1 ClevelandMedicalDevicesIncPipelineProducts&OngoingClinical TrialsOverview 43
5.9 ClinatecCompanyOverview44
5.9.1 ClinatecPipeline Products&OngoingClinical TrialsOverview 44
5.10 DeepBrain Innovations,LLCCompanyOverview 45
5.10.1 DeepBrain Innovations,LLCPipeline Products&OngoingClinical TrialsOverview45
5.11 Duke UniversityCompanyOverview50

4. 5.11.1 Duke UniversityPipeline Products&OngoingClinical Trials Overview 50
5.12 Functional NeuromodulationInc.CompanyOverview 51
5.12.1 Functional NeuromodulationInc.Pipeline Products&OngoingClinical TrialsOverview 51
5.13 HighlandInstruments,Inc.CompanyOverview 53
5.13.1 HighlandInstruments,Inc.Pipeline Products&OngoingClinical TrialsOverview 53
5.14 MassachusettsGeneral Hospital CompanyOverview 54
5.14.1 MassachusettsGeneral Hospital Pipeline Products&OngoingClinical TrialsOverview 54
5.15 MassachusettsInstitute of TechnologyCompanyOverview56
5.15.1 MassachusettsInstitute of TechnologyPipeline Products&OngoingClinical TrialsOverview56
5.16 Mayo ClinicUSCompanyOverview 57
5.16.1 Mayo ClinicUSPipelineProducts&OngoingClinical TrialsOverview 57
5.17 Medtronicplc CompanyOverview58
5.17.1 Medtronicplc Pipeline Products&OngoingClinical TrialsOverview 58
5.18 National Cheng-KungUniversityHospitalCompanyOverview 62
5.18.1 National Cheng-KungUniversityHospitalPipelineProducts&OngoingClinical TrialsOverview 62
5.19 NeuroProTechnologiesIncCompanyOverview63
5.19.1 NeuroProTechnologiesIncPipeline Products&OngoingClinical TrialsOverview 63
5.20 NeurosigmaIncCompanyOverview64
5.20.1 NeurosigmaIncPipeline Products&OngoingClinical TrialsOverview 64
5.21 Newronikas.r.l.CompanyOverview 66
5.21.1 Newronikas.r.l.PipelineProducts&OngoingClinical TrialsOverview 66
5.22 Nuraleve Inc.CompanyOverview 67
5.22.1 Nuraleve Inc.PipelineProducts&OngoingClinical TrialsOverview 67
5.23 Soterix Medical IncCompanyOverview 68
5.23.1 Soterix Medical IncPipelineProducts&OngoingClinical TrialsOverview68

5. 5.24 Sree ChitraTirunal Institute forMedical Sciences&TechnologyCompanyOverview 81
5.24.1 Sree Chitra Tirunal Institute forMedical Sciences &TechnologyPipelineProducts&Ongoing
Clinical TrialsOverview 81
5.25 St. Jude Medical IncCompanyOverview 83
5.25.1 St. Jude Medical Inc Pipeline Products&OngoingClinical TrialsOverview 83
5.26 SUNY Downstate Medical CenterCompanyOverview86
5.26.1 SUNY Downstate Medical CenterPipeline Products&OngoingClinical TrialsOverview86
5.27 The Universityof UtahCompanyOverview 87
5.27.1 The Universityof UtahPipelineProducts&OngoingClinical TrialsOverview 87
5.28 Universityof California LosAngelesCompanyOverview89
5.28.1 Universityof CaliforniaLosAngelesPipeline Products&OngoingClinical TrialsOverview 89
5.29 Universityof Central FloridaCompanyOverview 91
5.29.1 Universityof Central FloridaPipeline Products&OngoingClinical TrialsOverview 91
5.30 Universityof IllinoisCompanyOverview 93
5.30.1 Universityof IllinoisPipelineProducts&OngoingClinical TrialsOverview93
5.31 Universityof MichiganCompanyOverview 95
5.31.1 Universityof MichiganPipeline Products& OngoingClinical TrialsOverview 95
5.32 Universityof MilanCompanyOverview 96
5.32.1 Universityof MilanPipeline Products&OngoingClinical TrialsOverview 96
5.33 Universityof OxfordCompanyOverview97
5.33.1 Universityof OxfordPipeline Products &OngoingClinical TrialsOverview 97
5.34 Universityof SouthFloridaCompanyOverview98
5.34.1 Universityof SouthFloridaPipeline Products&OngoingClinical TrialsOverview 98
5.35 Wedge TherapeuticsCompanyOverview 99
5.35.1 Wedge Therapeutics Pipeline Products&OngoingClinical TrialsOverview 99
6 DeepBrainStimulators- RecentDevelopments100

6. 6.1 Nov28, 2016: BrainswayReportsContinuedFinancialGrowthforQ3 of 2016 100
6.2 Nov22, 2016: MedtronicReportsSecondQuarterFinancial Results 100
6.3 Nov16, 2016: MedtronicReleasesFY16IntegratedPerformanceReport103
6.4 Nov15, 2016: CEVA to workwithMedtronicfor distributionfacilityconstruction103
6.5 Nov01, 2016: SheppardPrattHealthSystemAppointsNew Chief FinancialOfficer104
6.6 Oct 26, 2016: BostonScientificAnnouncesResultsForThirdQuarter2016 104
6.7 Oct 19, 2016: St. Jude Medical ReportsThirdQuarter2016 Results106
6.8 Oct 13, 2016: BaylorCollege of Medicine researcherandcollaboratorsawardedgrantthroughNIH
BRAIN Initiative 107
6.9 Oct 10, 2016: ProfessorIanMeredithToJoinBostonScientificAsExecutive Vice PresidentAnd
Global Chief Medical Officer108
6.10 Oct 07, 2016: Directional deepbrainstimulationformovementdisordersnow beingused109
6.11 Oct 06, 2016: St. Jude Medical AnnouncesU.S.Launchand FirstImplantof New DeepBrain
StimulationSystemandDirectional LeadforPatientsSufferingfromMovementDisorders110
6.12 Sep28, 2016: Soterix Medical LaunchesPainXtDCSTreatmentinCanadawithHealthCanada
Approval 110
6.13 Sep15, 2016: MedtronicNamesMark Ploof SeniorVice Presidentof Global Operationsand
BusinessServices111
6.14 Aug 25, 2016: MedtronicReportsFirstQuarterFinancial Results112
6.15 Aug 17, 2016: JerseyShore UniversityMedical CenterisFirstHospital InNew JerseytoOfferDeep
Transcranial MagneticStimulation(DTMS) 114
6.16 Aug 03, 2016: DeepTranscranial MagneticStimulationEnablesControlledOpeningof Blood-Brain
Barrier115
6.17 Jul 28, 2016: BostonScientificAnnouncesResultsForSecondQuarter2016 115
6.18 Jul 21, 2016: TGA Hazard AlertOnMedtronicNeuromodulationDeepBrainStimulationsystem
pocketadaptors117
6.19 Jul 20, 2016: St. Jude Medical ReportsSecondQuarter2016 Results117
6.20 Jul 19, 2016: DeepBrainStimulationContinuesToShow Promise ForPatientsWithMild
Alzheimer’sDisease 119

7. 6.21 Jul 13, 2016: BostonScientificElectsYoshiakiFujimori toBoardof Directors120
6.22 Jun 30, 2016: NuVasiveAgreestoSettlePatentLitigationWith Medtronic120
6.23 Jun 16, 2016: TGA Hazard AlertonMedtronicdeepbrainstimulationtherapyDBSExtensionmodels
7483 and 37086 120
6.24 Jun 16, 2016: St.Jude Medical BroadensTreatmentOptionsforPatientsSufferingMovement
Disorderswiththe European Launchof New DeepBrainStimulationSystemandDirectional Lead121
6.25 Jun 15, 2016: Soterix Medical awarded$2.5MNIHgrant to run Phase-2EfficacyTrial to treat
AphasiaafterStroke withHD-tDCS121
6.26 Jun 08, 2016: BostonScientificAnnounces RestructuringProgramtoSupportLong-TermGrowth
and Innovation122
6.27 Jun 06, 2016: MedtronicOutlinesFutureGrowthVisionatInvestorDay123
6.28 May 31, 2016: MedtronicReportsFourthQuarterand Fiscal Year 2016 Financial Results123
6.29 May 27, 2016: AlevaNeurotherapeuticsRaisesUSD18MillioninSeriesCFinancingRound126
6.30 May 17, 2016: Soterix Medical,AnnouncestDCS-LTEDepressionTreatmentPartnershipProgram
for CliniciansandMedical CentersbasedonitsNon-invasive Neuromodulation Platform126
6.31 May 04, 2016: MedtronicWelcomesKarenL.Parkhill asItsNew Chief FinancialOfficer126
6.32 Apr 06, 2016: MedtronicStatementonU.S.Departmentof Treasury'sRecentTemporaryand
ProposedRegulations127
6.33 Apr 04, 2016: SheppardPrattHealthSystemNamesNew PresidentandCEO128
6.34 Mar 17, 2016: MedtronicProposesProxyAccess128
6.35 Mar 01, 2016: MedtronicReportsThirdQuarter Financial Results129
6.36 Feb19, 2016: Medtronicto Announce Financial ResultsforItsThirdQuarterof Fiscal Year2016 130
6.37 Feb17, 2016: FDA ApprovesMedtronicDeepBrainStimulationforPeople withParkinson'sDisease
withRecentOnsetof Motor Complications130
6.38 Feb02, 2016: ClinatecRaisesUSD10.6 MillioninVenture Financing132
6.39 Feb01, 2016: AlevaNeurotherapeuticsEntersintoAgreementwithGreatbatch132
6.40 Feb01, 2016: AlevaNeurotherapeuticstoRaise FundsinSeriesCFinancing132
6.41 Jan 14, 2016: Soterix Medical LaunchesPainXtDCSTreatmentinEU withCE Approval 132

8. 6.42 Jan 11, 2016: MedtronicUpdatesCapital AllocationPlansandFiscal 2016 EPS Guidance 133
6.43 Dec 29, 2015: Soterix Medical ReceivesCEMark Approval for1x1 tDCS DepressionTherapy134
6.44 Dec 14, 2015: The MedtronicBakkenInvitationAwardHonors12 PatientsfromAroundthe World
for GivingBack134
6.45 Dec 09, 2015: MedtronicAnnouncesFDA Approval forthe OnlyFull-BodyMRConditional Deep
Brain StimulationSystems135
7 Appendix137
7.1 Methodology137
7.2 AboutGlobalData140
7.3 Contact Us 140
7.4 Disclaimer140